Abstract
α2-Adrenergic agonists are responsible for a variety of physiological responses including analgesia. A total of 16 new chemical series that provide analgesia through an α2-adrenergic mechanism have been patented since 1997. There were also nine patents issued for known α2-adrenergic agonists, which have found new application as effective analgesic agents with a diminished side effect profile, such as use in combination with other analgesic agents or through specific routes of administration.